Improving market access strategy in pharma
Steering committees play a key role in addressing questions ranging from clinical insights and market penetration and expansion to issues around access and coverage.
Engaging global payers for better trial design
A clinical team wanted to design a Phase III trial for a new therapy used to treat a rare disease. To gauge economic viability, the team needed to understand how global payer organizations would weigh the benefits of the therapy and where the treatment might be placed in formularies.
Answering key questions with a HEOR advisory board
A HEOR virtual advisory board enabled a medical affairs team to develop a cost-effectiveness model. Read the success story to learn how.
Obtaining deeper insights in the pre-clinical stage
Reducing pre-clinical timelines is possible with insights management technology. Learn how one medical director did it.
Asynchronous global speaker training session
Oncology speaker training conducted asynchronously resulted in more engaged trainees. Read the success story to learn more.
Using virtual engagement to shorten trial design timelines
To shorten trial design timelines, a medical affairs team used a virtual platform to get candid feedback from KOLs. Read the case study.
Better patient outcomes at the heart of virtual engagement
The strategic benefits of virtual engagement are well-established. What’s in it for patients?
Commercial market research advisory board
Commercial teams can streamline data collection for competitive positioning and messaging. Read this case study to learn more.
Tips for strengthening KOL engagement in pharma
How to improve KOL engagement by deepening partnerships in a hybrid environment.
Streamlining publication development with real-time co-authoring
A multibillion-dollar global pharmaceutical firm became frustrated with the time-consuming and labor-intensive publication process and wanted to improve it. To achieve its primary goals of finalizing a manuscript more quickly and improving the overall experience for authors, the company decided to use a co-authoring platform to shorten timelines, keep proprietary information secure, and give authors more flexibility to make more thoughtful and thorough contributions.
In this success story, learn how a leading drug company leveraged co-authoring technology to simplify and expedite the manuscript development process.
